Literature DB >> 25038227

NACK is an integral component of the Notch transcriptional activation complex and is critical for development and tumorigenesis.

Kelly L Weaver1, Marie-Clotilde Alves-Guerra2, Ke Jin1, Zhiqiang Wang1, Xiaoqing Han1, Prathibha Ranganathan1, Xiaoxia Zhu1, Thiago DaSilva1, Wei Liu3, Francesca Ratti4, Renee M Demarest5, Cristos Tzimas6, Meghan Rice1, Rodrigo Vasquez-Del Carpio7, Nadia Dahmane8, David J Robbins1, Anthony J Capobianco9.   

Abstract

The Notch signaling pathway governs many distinct cellular processes by regulating transcriptional programs. The transcriptional response initiated by Notch is highly cell context dependent, indicating that multiple factors influence Notch target gene selection and activity. However, the mechanism by which Notch drives target gene transcription is not well understood. Herein, we identify and characterize a novel Notch-interacting protein, Notch activation complex kinase (NACK), which acts as a Notch transcriptional coactivator. We show that NACK associates with the Notch transcriptional activation complex on DNA, mediates Notch transcriptional activity, and is required for Notch-mediated tumorigenesis. We demonstrate that Notch1 and NACK are coexpressed during mouse development and that homozygous loss of NACK is embryonic lethal. Finally, we show that NACK is also a Notch target gene, establishing a feed-forward loop. Thus, our data indicate that NACK is a key component of the Notch transcriptional complex and is an essential regulator of Notch-mediated tumorigenesis and development. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25038227      PMCID: PMC4154994          DOI: 10.1158/0008-5472.CAN-14-1547

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation.

Authors:  Luke T Krebs; Yingzi Xue; Christine R Norton; John P Sundberg; Paul Beatus; Urban Lendahl; Anne Joutel; Thomas Gridley
Journal:  Genesis       Date:  2003-11       Impact factor: 2.487

3.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

4.  Eukaryotic gene transcription with purified components.

Authors:  J D Dignam; P L Martin; B S Shastry; R G Roeder
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic).

Authors:  C Ronchini; A J Capobianco
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.

Authors:  Yoshiharu Miyamoto; Anirban Maitra; Bidyut Ghosh; Ulrich Zechner; Pedram Argani; Christine A Iacobuzio-Donahue; Virote Sriuranpong; Tatsuya Iso; Ingrid M Meszoely; Michael S Wolfe; Ralph H Hruban; Douglas W Ball; Roland M Schmid; Steven D Leach
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

7.  Notch1 is essential for postimplantation development in mice.

Authors:  P J Swiatek; C E Lindsell; F F del Amo; G Weinmaster; T Gridley
Journal:  Genes Dev       Date:  1994-03-15       Impact factor: 11.361

8.  Presenilin-mediated transmembrane cleavage is required for Notch signal transduction in Drosophila.

Authors:  G Struhl; I Greenwald
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

9.  Disruption of the mouse RBP-J kappa gene results in early embryonic death.

Authors:  C Oka; T Nakano; A Wakeham; J L de la Pompa; C Mori; T Sakai; S Okazaki; M Kawaichi; K Shiota; T W Mak; T Honjo
Journal:  Development       Date:  1995-10       Impact factor: 6.868

10.  Notch1 is required for the coordinate segmentation of somites.

Authors:  R A Conlon; A G Reaume; J Rossant
Journal:  Development       Date:  1995-05       Impact factor: 6.868

View more
  14 in total

1.  Notch Represses Transcription by PRC2 Recruitment to the Ternary Complex.

Authors:  Xiaoqing Han; Prathibha Ranganathan; Christos Tzimas; Kelly L Weaver; Ke Jin; Luisana Astudillo; Wen Zhou; Xiaoxia Zhu; Bin Li; David J Robbins; Anthony J Capobianco
Journal:  Mol Cancer Res       Date:  2017-06-05       Impact factor: 5.852

2.  The BET bromodomain inhibitor I-BET151 acts downstream of smoothened protein to abrogate the growth of hedgehog protein-driven cancers.

Authors:  Jun Long; Bin Li; Jezabel Rodriguez-Blanco; Chiara Pastori; Claude-Henry Volmar; Claes Wahlestedt; Anthony Capobianco; Feng Bai; Xin-Hai Pei; Nagi G Ayad; David J Robbins
Journal:  J Biol Chem       Date:  2014-10-29       Impact factor: 5.157

3.  PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization.

Authors:  Mitchell L Lopez; Megan Lo; Jennifer E Kung; Małgorzata Dudkiewicz; Gwendolyn M Jang; John Von Dollen; Jeffrey R Johnson; Nevan J Krogan; Krzysztof Pawłowski; Natalia Jura
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-16       Impact factor: 11.205

4.  Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer.

Authors:  Céline Lecointre; Elise Fourgous; Ingrid Montarras; Clément Kerneur; Valérie Simon; Yvan Boublik; Débora Bonenfant; Bruno Robert; Pierre Martineau; Serge Roche
Journal:  Cancers (Basel)       Date:  2022-06-16       Impact factor: 6.575

5.  The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis.

Authors:  Luisana Astudillo; Thiago G Da Silva; Zhiqiang Wang; Xiaoqing Han; Ke Jin; Jeffrey VanWye; Xiaoxia Zhu; Kelly Weaver; Taiji Oashi; Pedro E M Lopes; Darren Orton; Leif R Neitzel; Ethan Lee; Ralf Landgraf; David J Robbins; Alexander D MacKerell; Anthony J Capobianco
Journal:  Cancer Res       Date:  2016-04-13       Impact factor: 12.701

6.  AURKA promotes cell migration and invasion of head and neck squamous cell carcinoma through regulation of the AURKA/Akt/FAK signaling pathway.

Authors:  Jichang Wu; Liyun Yang; Yamin Shan; Changping Cai; Shili Wang; Hao Zhang
Journal:  Oncol Lett       Date:  2016-01-14       Impact factor: 2.967

Review 7.  The pseudokinases SgK269 and SgK223: A novel oncogenic alliance in human cancer.

Authors:  Rachelle L O'Rourke; Roger J Daly
Journal:  Cell Adh Migr       Date:  2017-12-21       Impact factor: 3.405

8.  Pharmacological Disruption of the Notch1 Transcriptional Complex Inhibits Tumor Growth by Selectively Targeting Cancer Stem Cells.

Authors:  William Guerrant; Luisana Astudillo; Annamil Alvarez-Trotta; Mohini Lahiry; Giulia Diluvio; Elena Shersher; Hugo Kaneku; David J Robbins; Darren Orton; Anthony J Capobianco
Journal:  Cancer Res       Date:  2021-04-05       Impact factor: 12.701

9.  Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.

Authors:  Neha Woods; Jose Trevino; Domenico Coppola; Srikumar Chellappan; Shengyu Yang; Jaya Padmanabhan
Journal:  Oncotarget       Date:  2015-11-03

Review 10.  The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer.

Authors:  Adriana Harbuzariu; Gabriela M Oprea-Ilies; Ruben R Gonzalez-Perez
Journal:  Medicines (Basel)       Date:  2018-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.